- Wednesday, February 7, 2018 at 4:10PM - 6:00PM
- Room 127
- Open To The Public
- Add to Calendar:
Prices of prescription drugs in the United States have increased dramatically over the past decade. In the US, the average annual per-patient spending on insulin has tripled in the past 10 years - increasing from $231 to $736 - though there have been no meaningful changes in the medicine itself. What happens when people who rely on medications for their health and well-being find they can no longer afford them?
This event uses insulin as a case study to examine drug pricing in the United States, discuss the impact of rising drug prices on patients with diabetes, and point the way to solutions to curb prices and improve accessibility.
Join patients, clinicians, lawyers, and advocates passionate about lowering prescription drug prices via courts, legislation, and other forms of advocacy for a panel discussion followed by Q&A.
Yale Global Health Justice Partnership, Yale US Health Justice Collaborative, Yale Network for Global NCDs
Funded by the Oscar M. Ruebhausen Fund at Yale Law School